Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Cubist Pharmaceuticals CEO and leadership

Zippia score 4.8
OverviewSalaryRevenue

Reviews

DemographicsCompetitors

CEO & Executives

Cubist Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Michael Bonney is the Cubist Pharmaceuticals's CEO. Cubist Pharmaceuticals has 873 employees, of which 11 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Cubist Pharmaceuticals executive team is 18% female and 82% male.
  • 57% of the management team is White.
  • 17% of Cubist Pharmaceuticals management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work at Cubist Pharmaceuticals?
Share your experience

Rate Cubist Pharmaceuticals' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Michael Bonney

CEO

Michael Bonney's LinkedIn

John Clarke

Founder

Paul Schimmel

Founder

John Mustillo

Board Member

Sunil Patel

Board Member

Daryl Mims

Global Business Partner, CEO/CIO and Many Vps

Daryl Mims is a Global Business Partner, CEO/CIO and many VPs at CUBIST PHARMACEUTICALS INC and is based in Sewaren, New Jersey. He has experience at NBA and has worked as Desktop Support / Consultant at Verizon Corporate HQ and Helpdesk Analyst at MEDCO HEALTH SOLUTIONS INC. Daryl attended Bayonne High School between 1991 and 1995.

Kenneth Bate

Board Member

Martin Rosenberg

Board Member

Patrick Vink

Member Board of Directors

Patrick Vink's LinkedIn

Management experience at global executive committee level in multi billion dollar pharma companies

Specialties: General management at global level

Biotechnology, manufacturing, commercial management, boardroom consultancy

Rachel Stahler

Chief Information Officer For Optimer Pharmaceuticals

Rachel Stahler is a Chief Information Officer for Optimer Pharmaceuticals at CUBIST PHARMACEUTICALS INC and is based in Jersey City, New Jersey.

Do you work at Cubist Pharmaceuticals?

Does the leadership team provide a clear direction for Cubist Pharmaceuticals?

Cubist Pharmaceuticals jobs

Cubist Pharmaceuticals founders

Name & TitleBio
John Clarke

Founder

Paul Schimmel

Founder

Cubist Pharmaceuticals board members

Name & TitleBio
John Mustillo

Board Member

Sunil Patel

Board Member

Kenneth Bate

Board Member

Martin Rosenberg

Board Member

Cubist Pharmaceuticals leadership demographics

Cubist Pharmaceuticals gender distribution in management team

  • The Cubist Pharmaceuticals executive team is 18% female and 82% male.
  • Cubist Pharmaceuticals is 48% female and 52% male company-wide.
Male
Male
82%
Company-wide: 52%
Female
Female
18%
Company-wide: 48%

Cubist Pharmaceuticals executives by race

Management Team:
  • The most common ethnicity among Cubist Pharmaceuticals executive officers is White.
  • 57% of the management team is White.
  • 17% of Cubist Pharmaceuticals's management is Hispanic or Latino.
  • 14% of the management team is Asian.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 60% of employees are White.
  • 17% of employees are Asian.
  • 12% of employees are Hispanic or Latino.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Cubist Pharmaceuticals jobs nearby

Cubist Pharmaceuticals executives FAQs

Related company executives

Working at related companies

Related company jobs

Cubist Pharmaceuticals highest paying jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Cubist Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cubist Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Cubist Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cubist Pharmaceuticals. The data presented on this page does not represent the view of Cubist Pharmaceuticals and its employees or that of Zippia.

Cubist Pharmaceuticals may also be known as or be related to Cubist Pharmaceuticals, Cubist Pharmaceuticals INC, Cubist Pharmaceuticals LLC, Cubist Pharmaceuticals, INC and Cubist Pharmaceuticals, Inc.